The DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index.
Serum therapy revisited: animal models of infection and development of passive antibody therapy
Open accessOverview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinical benefit was demonstrated for invasive bacterial infections (Casadevall & Scharff, 1994), for various viral diseases (Janeway, 1945; Hammon et al, 1953), as well as for anti‐fungal therapy (Bugli et al, 2013)”
From mRNA mediates passive vaccination against infectious agents, toxins, and tumors (2017) · cites this paper as Casadevall & Scharff, 1994
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
Köhler, G., & Milstein, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,200
The principles and practice of medicine
(1938) · The American Journal of Surgery · doi:10.1016/s0002-9610(38)91188-2 · Cited by 1,657
Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.
LoBuglio, A. F., Wheeler, R. H., Trang, J. M., Haynes, A., Rogers, K., Harvey, E. B., Sun, L., Ghrayeb, J., & Khazaeli, M. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.4220 · Cited by 524
Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.
Schroff, R. W., Foon, K. A., Beatty, S. M., Oldham, R. K., & Morgan, A. C. (1985) · PubMed · Cited by 488
THE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS
Flexner, S. (1913) · The Journal of Experimental Medicine · doi:10.1084/jem.17.5.553 · Cited by 175
Cooper, G. M., Rosenstein, C., Walter, A. W., & Peizer, L. R. (1932) · The Journal of Experimental Medicine · doi:10.1084/jem.55.4.531 · Cited by 96
SEROLOGICAL RELATIONSHIPS AMONG MENINGOCOCCI
Branham, S. E. (1953) · Bacteriological Reviews · doi:10.1128/br.17.3.175-188.1953 · Cited by 84
In Vitro Antibodies: Strategies for Production and Application
Morrison, S. L. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.001323 · Cited by 83
Experimental Meningococcal Infection in Mice
Miller, C. P. (1933) · Science · doi:10.1126/science.78.2024.340 · Cited by 77
A BIOLOGIC CLASSIFICATION OF PNEUMOCOCCI BY MEANS OF IMMUNITY REACTIONS
Dochez, A. R. (1913) · JAMA · doi:10.1001/jama.1913.04350100005003 · Cited by 74
Cited by
Sorted by citations
Vaccines for preventing pneumococcal infection in adults
Moberley, S. A., Holden, J., Tatham, D. P., & Andrews, R. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub3 · Cited by 970
The convalescent sera option for containing COVID-19
Casadevall, A., & Pirofski, L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138003 · Cited by 904
Self-citationDeployment of convalescent plasma for the prevention and treatment of COVID-19
Bloch, E. M., Shoham, S., Casadevall, A., Sachais, B. S., Shaz, B. H., Winters, J. L., van Buskirk, C. M., Grossman, B. J., Joyner, M. J., Henderson, J. P., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138745 · Cited by 805
Self-citationAn Update on Current Therapeutic Drugs Treating COVID-19
Wu, R., Wang, L., Kuo, H. D., Shannar, A., Peter, R. M., Chou, P. J., Li, S. N., Hudlikar, R. R., Liu, X., Liu, Z., et al. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00216-7 · Cited by 600
Passive antibody therapy for infectious diseases
Casadevall, A., Dadachova, E., & Pirofski, L. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro974 · Cited by 542
Self-citation
Metadata
- Authors
- Casadevall, A., & Scharff, M. D.
- Affiliations
- Albert Einstein College of Medicine (US)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1994-08
- Volume
- 38
- Issue
- 8
- Pages
- 1695-1702
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC284624
- OpenAlex
- W2031152984
- Cited by
- 251
- References
- 84
- Citations by year
- 2025: 8 · 2024: 6 · 2023: 10 · 2022: 10 · 2021: 20 · 2020: 29 · 2019: 5 · 2018: 7 · 2017: 10 · 2016: 4 · 2015: 6 · 2014: 12 · 2013: 6 · 2012: 8
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-39839)
- National Institute of Allergy and Infectious Diseases (AI13342, AI33774, R01AI033774)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Health Sciences › Medicine › Pharmacology (medical) › Historical Medical Research and Treatments
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- serum therapy, animal models of infection, passive antibody therapy, passive immunization
- MeSH terms
- Animals, Disease Models, Animal, Humans, Immunization, Passive, Meningitis, Meningococcal, Pneumococcal Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
